NCT07398365 Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients
| NCT ID | NCT07398365 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Edinburgh |
| Condition | Bipolar Affective Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-04-03 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-04-03 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study will characterise the general psychiatric and general medical phenotypes of 100 adults, sequentially admitted to NHS General Adult Psychiatry (GAP) "mental health" inpatient wards, providing the first detailed information on morbidity in this patient population.
Eligibility Criteria
Inclusion: \- Adults aged between 18 and 65 years admitted to GAP wards during recruitment period Exclusion: \- Admissions to non-GAP wards (e.g., forensic psychiatry, young people's units, perinatal, old age psychiatry, or general medical wards)
Contact & Investigator
Douglas Steele
STUDY DIRECTOR
University of Dundee
Frequently Asked Questions
Who can join the NCT07398365 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Bipolar Affective Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07398365 currently recruiting?
Yes, NCT07398365 is actively recruiting participants. Contact the research team at david.hayward@nhslothian.scot.nhs.uk for enrollment information.
Where is the NCT07398365 trial being conducted?
This trial is being conducted at Livingston, United Kingdom.
Who is sponsoring the NCT07398365 clinical trial?
NCT07398365 is sponsored by University of Edinburgh. The principal investigator is Douglas Steele at University of Dundee. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.